Inclusion and exclusion criteria
Inclusion criteria :(1) Randomized controlled trials or single-arm trials;
(2) Patients diagnosed with relapsed/refractory DLBCL;
(3) At least one of the efficacy indicators of OS, PFS or ORR was reported;
(4) The treatment are chemotherapy, targeted therapy, and immunotherapy alone or in combination.
Exclusion criteria :
(1) Sample size was less than 10;
(2) Patients with other subtypes, DLBCL transformed from other subtypes, or patients with high-risk disease with undiagnosed relapsed/refractory DLBCL.
Details of
search and inclusion
Literature search : Databases : PubMed , Embase and Cochrane Library
Search deadline : Jan 25, 2021.
Language was limited to English.
The terms used : “relapsed”, “refractory” and “diffuse large B-cell lymphoma” .
Literature inclusion and exclusion:
A total of 854 literatures were identified
624 literatures were screened
106 literatures were assessed for eligibility
58 studies were included in the analysis.
Download more
Detailed search strategies download
PRISMA flow diagram download
